Stay updated on Avelumab Combo Regimens in R/R DLBCL Clinical Trial
Sign up to get notified when there's something new on the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page.

Latest updates to the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page
- Check6 days agoChange DetectedA government funding notice banner was added, the page revision updated from v3.4.0 to v3.4.1, and the previous revision note v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check13 days agoChange DetectedAdded a glossary toggle and updated metadata/version text (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), replacing the previous wording (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedMinor site update: Revision: v3.3.4 added and Revision: v3.3.3 removed; there is no impact on the study content or page navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedThe study locations section was expanded to include new sites across the United States (CA, KY, LA, MA, MI, MN, NY), Australia (NSW, Victoria), Belgium, Italy, Poland (Lesser Poland Voivodeship, Lublin Voivodeship), and Korea, and several previously listed locations were removed. This change expands and clarifies where recruitment may take place.SummaryDifference0.9%

- Check71 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check78 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed and may not be about the study, and updated the revision tag to v3.3.1. The previous PubMed publication note and revision tag v3.2.0 were removed/updated to reflect the new wording.SummaryDifference0.1%

Stay in the know with updates to Avelumab Combo Regimens in R/R DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page.